﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Academy of Medical Sciences of I.R. Iran</PublisherName>
      <JournalTitle>Archives of Iranian Medicine</JournalTitle>
      <Issn>1029-2977</Issn>
      <Volume>21</Volume>
      <Issue>8</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2018</Year>
        <Month>08</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Use of Some Additives for Improving Mesenchymal Stem Cell Isolation Outcomes in Non-Mobilized Peripheral Blood</ArticleTitle>
    <FirstPage>362</FirstPage>
    <LastPage>367</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Noushin</FirstName>
        <LastName>Pouryazdanpanah</LastName>
      </Author>
      <Author>
        <FirstName>Reza</FirstName>
        <LastName>Vahidi</LastName>
      </Author>
      <Author>
        <FirstName>Shahriar</FirstName>
        <LastName>Dabiri</LastName>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Derakhshani</LastName>
      </Author>
      <Author>
        <FirstName>Alireza</FirstName>
        <LastName>Farsinezhad</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">
      </ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>10</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>05</Month>
        <Day>12</Day>
      </PubDate>
    </History>
    <Abstract>Background: The mesenchymal stem cells (MSCs) of peripheral blood (PB) have been recognized as a promising source for allogeneic cell therapy. The objective of the present study was to isolate and characterize MSCs derived from non-mobilized PB, and evaluate their differentiation potential. Methods: The buffy coat mononuclear fractions of the PB were concentrated using the Ficoll-Paque density gradient centrifugation and were grown on primary and secondary culture media, respectively. The isolated cells were characterized using a multidisciplinary approach which was based on morphology, immunophenotyping, gene expression, and multipotentiality. Flow cytometry and Reverse transcription polymerase chain reaction (RT-PCR) were used to identify the expression of different MSC markers. Finally, after culturing in osteogenic and adipogenic induction media, the isolated cells were stained by Alizarin red and Oil-Red O. Results: In spite of absence of any bone marrow stimulating factor, the isolation approach in this study yielded a rather homogeneous and spindle-shaped mononuclear cell population (the yield of passage 0 was 0.65 ± 0.15) that stained positive for CD90, CD105, and CD73, and were negative for CD45 and CD34. These cells have high proliferative capacity (confirmed by the expression of Oct-4, Nucleostemin, and Nanog genes) and were able to differentiate into lineage-specific committed cells, when exposed to the appropriate medium. Conclusions: Overall, it can be concluded that conventional, labour-intensive and time-consuming approaches are not necessary in isolating MSCs from PB. This relatively accessible and minimally invasive source, PB, represents a good alternative reservoir of homogeneous MSCs that could open a new era for practical exploitation in regenerative medicine.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Differentiation</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Mesenchymal stem cells</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Peripheral blood</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Regenerative medicine</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>